Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease

Ting Zhou1,2, Zhiyuan Chen2, Hongchao Li1

  • 1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.

Insights

Discrepancies in health utilities used in cardiovascular disease cost-utility analyses (CUAs) are common. Authors must cite original studies and be transparent about utility selection to ensure CUA credibility.

Area of Science:

  • Health economics
  • Medical decision making
  • Cardiovascular disease research

Background:

  • Health utilities are crucial for quality-adjusted life years in cost-utility analysis (CUA).
  • Improper use of published health utilities can undermine CUA credibility.

Purpose of the Study:

  • To identify and analyze discrepancies in the application of published health utilities within cardiovascular disease (CVD) cost-utility analyses.

Main Methods:

  • Reviewed 585 CVD CUAs from the Tufts Cost-Effectiveness Analysis Registry.
  • Compared 2235 health utilities from 442 CUAs against 203 original utility studies.
  • Utilized logistic regression to identify factors predicting discrepancies.

Main Results:

  • Only 26.7% of health utilities matched original descriptions and values.
  • 44.3% differed in both description and value, often due to disease severity.
  • 87.4% of value discrepancies lacked justification.

Conclusions:

  • Significant discrepancies exist in health utility usage for CVD CUAs.
  • Authors must reference original utility studies and ensure transparency in selection and application.
  • Accurate health utility reporting is essential for reliable cost-utility analyses.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
573
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
62
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
932
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.8K